Abstract Interleukin-10 (IL-10) expression was significantly elevated upon stimulation with lipopolysaccharide (LPS) when the sialic acid-recognizing Igsuperfamily lectin Siglec-5 or -9 was overexpressed in RAW264 cells. During the course to clarify the mechanism for this activation, we found that IL-10
Introduction
Innate immunity functions as a pathogen sensor and contributes to protection against pathogens and the establishment of adaptive immunity. A group of transmembrane proteins, Toll-like receptors (TLRs), recognizes components of bacteria, viruses, and fungi as a pattern-recognition receptor to activate the first line of defense against pathogens (Kondo et al. 2012; West et al. 2006) . For example, lipopolysaccharide (LPS) was recognized by TLR4 and induced strong immune responses including inflammation.
Siglecs are sialic acid-recognizing Ig-superfamily lectins mainly expressed in immune cells (Crocker et al. 2012; Pillai et al. 2012 ). Members of CD33-related Siglecs have been shown to down-regulate both innate and acquired immune responses, and this may occur via cytosolic immunoreceptor tyrosinebased inhibitory motifs (ITIMs). We previously reported that Siglec-9, a member of CD33-related Siglecs, inhibited the production of proinflammatory cytokines and enhanced that of anti-inflammatory cytokine interleukin-10 (IL-10), induced by various ligands for TLRs. The ITIMs of Siglec-9 were previously shown to play an indispensable role in modulating the expression of cytokines (Ando et al. 2008 ).
CCAAT/enhancer-binding protein (C/EBP) family proteins are a member of the basic region-leucine zipper (bZIP) proteins including C/EBPa, b, c, d, and f (Nerlov 2008) . C/EBPs play central roles in many physiological processes such as liver metabolism, adipogenesis, and hematopoiesis, and these transcription factors form complexes with a wide variety of other transcription factors. Among the C/EBPs, C/EBPb plays an important role in adipose differentiation and innate immunity. Three isoforms of C/EBPb have been identified: LAP*, LAP, and LIP, and these are translated from the same mRNA, but from different initiation codons (Descombes and Schibler 1991) . LAP and LAP* were shown to be transactivators, whereas LIP is a repressor. The balance between LAP and LIP was reported to have a marked effect on C/EBPb-mediated transcriptional regulation (Li et al. 2008; Schroeder-Gloeckler et al. 2007) . IL-10 is produced by macrophages upon LPS stimulation, which seems to constitute a negative feedback regulation of inflammation by its potent antiinflammatory activity (Saraiva and O'Garra 2010) . IL-10 promoter contained several binding sites for C/EBPb, which were required for LPS-induced transactivation of IL-10 (Liu et al. 2003) . It is also reported that C/EBPb was induced by LPS with or without IFN-c stimulation (Bradley et al. 2003; Ruffell et al. 2009 ), which was shown to be necessary for the production of IL-10 in macrophages (Ruffell et al. 2009 ). In the present study, the role of C/EBPb in the increased expression of IL-10 in Siglec-9-expressing cells was studied.
Materials and methods

Reagents
LPS from Escherichia coli 0111:B4 was purchased from Sigma Aldrich (St Louis, MO, USA). Anti-C/ EBPb (sc-150) and anti-actin (AC-15) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and R&D Systems (Minneapolis, MN, USA), respectively. The OptEIA ELISA set for IL-10 was from BD PharMingen (San Jose, CA, USA).
Plasmid construction
To construct the mouse IL-10 promoter-luciferase reporter plasmid, the promoter region was amplified from mouse genomic DNA by PCR using the following forward primers: 5 0 -CATACGCGTATCAGCCCT CTCGGGGTTTC-3 0 (for -500) 5 0 -CATACGCGTA CGTGTAGCATTGCCCCCC-3 0 (for -1,000), 5 0 -CA TACGCGTGATCTCTGATCTACAGCAGTGTGTC-3 0 (for -1,500) and reverse primer: 5 0 -CATCTCGAG GATGGAGCTCTCTTTTCTGCAAGG-3 0 (MluI and XhoI sites used for cloning are underlined). The amplified DNA fragments were introduced into the pGL3-basic vector (Promega, Madison, WI, USA).
The expression plasmid for the isoforms of mouse C/EBPb: LAP*, LAP, and LIP were constructed by inserting PCR fragments into pcDNA4 (Invitrogen, Carlsbad, CA, USA). The primers used were as follows. Forward primers: 5 0 -CATAAGCTTACCAT GCACCGCCTGCTGGC-3 0 for LAP*, 5 0 -CATGAAT TCGCCATGGAAGTGGCCAAC-3 0 for LAP and 5 0 -CATGAATTCACCATGGCGGCCGGTTTC-3 0 for LIP; common reverse primer: 5 0 -CATCTCGAGGCA GTGGCCCGCCGAGG-3 0 (HindIII or EcoRI and XhoI sites used for cloning are underlined), in which the endogenous stop codon was omitted to add the His tag at the C-terminus.
Cells
The macrophage cell line RAW264 and its derivative expressing Siglec-9 was described previously (Ando et al. 2008 ). These cells were maintained in RPMI1640 (Nissui, Tokyo, Japan) containing 10 % heat-inactivated fetal calf serum (PAA Laboratories, Pasching, Austria), 0.03 % L-glutamine (Wako, Osaka, Japan), 5 9 10 -5 M 2-mercaptoethanol (Wako), 100 U/ml penicillin G (Wako), and 100 lg/ml streptomycin (Wako).
Knockdown of C/EBPb by small interfering RNA (siRNA)
The following double-stranded RNA oligonucleotides were used as siRNA: 5 0 -CAGCCGGGCCCUGAGUA AUCACUUA-3 0 (siRNA1) and 5 0 -CGCGAGAGCUC AGCACCCUGCGGAA-3 0 (siRNA2). These siRNAs (50 nM) were introduced into RAW264 cells (1.5 9 10 4 ) seeded in 96-well plates using Lipofectamine 2000 (Invitrogen) by reverse transfection as recommended by the supplier, and medium was changed after 24 h. Cells were then stimulated by LPS (500 ng/ml) at 48 h post-transfection. The supernatant was harvested 8 h after stimulation, and the amount of IL-10 was determined by ELISA. Cells were lysed with SDS-sample buffer and used for western blotting analysis to confirm the reduction of C/EBPb.
Luciferase assay
Cells (3 9 10 5 ) were seeded into 24-well plates and were transfected with reporter plasmids using Fu-GENE HD (Promega) after 24 h culture. The plasmids containing luciferase reporter (1.8 lg) were transfected with that containing Renilla luciferase expressed by the thymidine kinase (TK) promoter (0.2 lg). The medium was changed 24 h after transfection, and LPS (500 ng/ml) was added 48 h post-transfection followed by 8 h stimulation. Reporter assays were performed with the dual luciferase assay kit (Promega) according to the manufacturer's instructions. Luciferase activity was measured with a luminometer (Atto, Tokyo, Japan), and normalized to Renilla luciferase activity. In some experiments, cells were transfected with 1.0 lg LAP expression vector (Dohda et al. 2004) along with the luciferase reporter (0.9 lg) and TKRenilla control (0.1 lg) vectors.
Chromatin immunoprecipitation (ChIP) assay Cells (1.0 9 10 7 ) were stimulated with LPS (500 ng/ml) for the indicated period and cross-linked with 1 % formaldehyde in phosphate-buffered saline at 37°C for 10 min. Harvested cells were suspended in a lysis buffer [1 % SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.0), and 1 mM phenylmethylsulfonyl fluoride (PMSF)] and sonicated. The samples were precleared with salmon sperm DNA-conjugated protein A agarose (Upstate Biotechnology, Lake Placid, NY, USA) in a dilution buffer [0.01 % SDS, 1.1 % Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HC1 (pH 8.1), 16.7 mM NaCl, 1 mM PMSF] and incubated with 2 lg of anti-C/EBPb antibody. The precipitates with salmon sperm DNA-conjugated protein A agarose were washed, and DNA was eluted with an elution buffer (1 % SDS in 0.1 M NaHCO 3 ) and incubated at 65°C for 24 h in the presence of 0.4 M NaCl. DNA samples were digested with proteinase K at 45°C for 2 h followed by purification with a kit (QIAquick Nucleotide Removal Kit, Qiagen, Tokyo, Japan). Immunoprecipitated DNA and input DNA were analyzed by real-time PCR with LightCycler (Roche Diagnostics, Tokyo, Japan) using 5 0 -TCCGAGTCAG-CAAGAAATATCGGACG-3 0 (as a forward primer) and 5 0 -TTCCTGAGGCAGACAGCTGTTCTATG-3 0 (as a reverse primer) to amplify the fragment located in the IL-10 promoter region from -452 to -276. Data are shown as the mean ± standard deviation. Statistical significances were determined by Student's t test.
Results IL-10 production was mainly regulated within 500 bp upstream region in Siglec-9-expressing cells
The promoter proximal regions of IL-10 were cloned and fused to the luciferase reporter gene. The recombinant plasmids containing three different IL-10-promoter flanking regions were introduced in RAW264 cells, and reporter activity was subsequently measured (Fig. 1 ). Although stimulation with LPS was supposed to be essential for the production of IL-10, basal levels of luciferase activity were observed in mock-transfected control cells without stimulation. A Fig. 1 The expression of IL-10 was mainly regulated by the region up to 500 bp upstream from the transcriptional start site. RAW264 cells that expressed Siglec-9 were transfected with luciferase reporter constructs containing truncated IL-10 promoter/enhancer regions (-1,500 to ?65, -1,000 to ?65, and -500 to ?65, in which ?1 indicates the transcriptional start site). Forty-eight hours after the transfection, cells were stimulated with 500 ng/ml of LPS for 8 h, and luciferase activity was then measured. Data are expressed as mean value with standard deviation of four independent experiments. Open bar mock-transfected control cells; solid bar Siglec-9-expressing cells. *p \ 0.05 versus mock-transfected control cells markedly higher activity level was observed either with or without the LPS stimulation in Siglec-9-expressing cells. In this case, luciferase activity appeared to be independent of the size of the promoter/enhancer region: similar activity levels were observed in the fragment up to -500 bp and that up to -1,500 bp. These results suggest that a major control region, except for a far upstream region (Saraiva and O'Garra 2010) , for the production of IL-10 in Siglec-9-expressing cells resides up to -500 bp in the IL-10 promoter/enhancer region.
C/EBPb regulated IL-10 production in Siglec-9-expressing cells
The binding sites for C/EBPb and Sp1 were reported in this region (up to -500 bp) of the mouse IL-10 gene (Saraiva and O'Garra 2010) . The deletion of a DNA sequence between -423 and -362 containing C/EBP binding sites caused a marked decrease in luciferase activity (data not shown). Thus, we analyzed the effects of C/EBPb on the production of IL-10. The expression levels of C/EBPb were measured in mocktransfected and Siglec-9-expressing cells. LAP and LIP levels increased in both cell types after the stimulation with LPS, and LAP and LIP levels in Siglec-9 cells were almost twice that of control cells after the stimulation (Fig. 2) . On the other hand, LAP* was not abundant. These indicated that C/EBPb was involved in the increased level of IL-10 produced in Siglec-9-expressing cells. Thus, LAP, a major form of C/EBPb, was transiently expressed and luciferase activity was measured with the reporter construct containing the IL-10 promoter/enhancer region (Fig. 3) . In the mock-transfected control cells, the expression of LAP down-regulated reporter activity either in the presence or absence of the LPS stimulation. On the other hand, LAP modestly stimulated the activity in Siglec-9-expressing cells either in the presence or absence of LPS, suggesting that LAP only enhanced promoter activity in Siglec-9-expressing cells. To clarify the mechanism underlying this activation, the derivatives of C/EBPb, His-tagged LAP*, LAP and LIP were separately expressed under similar conditions to those shown in Fig. 3 . Figure 4a shows the expression levels of the C/EBPb derivatives; the amount of His-LAP was threefold that of endogenous LAP in Siglec-9-expressing cells. IL-10 was near the minimum detection levels in mocktransfected control cells in the absence of the LPS stimulation, and only a low level of IL-10 was produced in Siglec-9-expressing cells (Fig. 4b) . In the presence of LPS stimulation, IL-10 production was weakly induced in mock-transfected control cells, while strong induction was observed for Siglec-9-expressing cells. On the other hand, stimulation seemed relatively weak in luciferase assay (Fig. 1) , as reported (Liu et al. 2003) , which may be due to the 
Mock
Siglec-9 Fig. 2 The expression level of C/EBPb was higher in Siglec-9-expressing cells with LPS stimulation. Cells were stimulated with 500 ng/ml of LPS for the indicated period and the whole cell lysate was subjected to western blotting using the anti-C/ EBPb antibody. Representative of four independent experiments is shown fact that luciferase plasmids contained just the promoter proximal region without other factors such as far upstream enhancers and epigenetic information (Saraiva et al. 2005; Zhang et al. 2006) . IL-10 production that was induced by LPS stimulation was reduced by LAP*, LAP, and LIP in mock-transfected control cells, however it increased by almost 1.7-fold in Siglec-9-expressing cells with LAP. LIP reduced the expression in a parallel experiment using Siglec-9-expressing cells, while LAP* did not have a strong effect (Fig. 4b) . These results suggested that LAP stimulated the production of IL-10 in Siglec-9-expressing cells as with the case of luciferase reporter assay shown in Fig. 3 .
We then determined the effects of C/EBPb on IL-10 production in an inverse experimental set using siRNA (Fig. 5) . In mock-transfected control cells, LAP levels were reduced to almost 50 % by specific siRNAs compared with those of scramble RNA-transfected cells, and a low level of IL-10 production was observed in the presence of the LPS stimulation. LAP expression levels in Siglec-9-expressing cells were reduced to 20-30 % by siRNAs compared with scramble RNA. IL-10 production was decreased by the knockdown, and the extent of the reduction appeared to be approximately proportional to the decrease in LAP either in the presence or absence of the LPS stimulation. We then investigated whether the binding of C/EBPb to the IL-10 promoter/enhancer region was increased in Siglec-9-expressing cells by ChIP analysis. As shown in Fig. 6 , the binding of C/EBPb was almost equal between control and Siglec-9-expressing cells without the LPS stimulation, but increased with the LPS stimulation in both cells. C/EBPb binding to the IL-10 promoter in Siglec-9-expressing cells was almost threefolds that of control cells 6 h after LPS stimulation. This result was in accordance with the increased amount of intracellular C/EBPb observed in Siglec-9-expressing cells, as shown in Fig. 2 . Among the C/EBPs, binding of C/EBPb and d was reported at this site (Liu et al. 2003) . However, no obvious changes were observed in C/EBPd binding between these two cell types (data not shown).
Discussion
C/EBPb and d as well as Sp1 are known to activate the expression of mouse IL-10 (Saraiva and O'Garra 2010) , and stimulation by LPS is a prerequisite for this activation. As shown in Figs. 3 and 4, the LPS stimulation was necessary for the production of IL-10 in both mock-transfected and Siglec-9-expressing cells, and an increase in C/EBPb levels may have primarily led to the enhanced production of IL-10 in Siglec-9-expressing cells. The expression of C/EBPb was previously shown to be regulated at the transcriptional level upon TLR stimulation, and enhanced CREB binding at the C/EBPb promoter was reported as the reason for the induction of C/EBPb in macrophages (Niehof et al. 1997 ). Thus, we examined the expression level of CREB by RT-PCR; however, our preliminary results did not support the enhanced expression of CREB as the reason for the higher induction of C/EBPb in Siglec-9-expressing cells. Therefore, the mechanism how C/EBPb level increased in Siglec-9-expressing cells remains to be elusive. Siglecs negatively control innate immunity by recruiting tyrosine phosphatase SHP-1 and -2 through their ITIMs (Crocker et al. 2012; Pillai et al. 2012 ). However, we could not demonstrate direct link between increased IL-10 production and the recruitment of SHPs. In the present study, an increase in intracellular C/EBPb by transient transfection stimulated the production of IL-10 only in Siglec-9-expressing cells (Fig. 4) ; therefore, Siglec-9-expressing cells may possess an additional mechanism other than the increase of C/EBPb protein, which contributes to the enhanced production of IL-10. The expression of IL-10 could be regulated by various factors: for instance, tyrosine phosphorylation of STAT3 was important for the IL-10 production under a specific condition (Ziegler-Heitbrock et al. 2003) . However, it has not been assessed whether recruitment of SHPs affects the phosphorylation status because cells contain large amount of SHP molecules, possibly more than the levels that Siglecs can sequester from cytosol. Phosphorylation may affect transcriptional activity of C/EBPs, but major phosphorylation sites were serine/threonine and not tyrosine (Nerlov 2008) . Thus, the additional roles of Siglecs in increased production of IL-10 are remained to be investigated for further study. In addition to transcription factors, epigenetic changes such as modifications of chromatin may also affect the expression of IL-10. We found that histone H4 acetylation, a hallmark for active chromatin, around the C/EBPb site was higher in Siglec-9-expressing cells (Shoji et al.; unpublished results) . The mechanistic reason currently remains unknown; however, such a difference may be linked to the strong and early production of IL-10 in Siglec-9-expressing cells in addition to the increased level of C/EBPb. LPS and several RNA viruses induced the expression of mouse Siglec-E in bone marrow-derived macrophages (Boyd et al. 2009 ) and Siglec-G in peritoneal macrophages (Chen et al. 2013) , respectively. Considering our results of relatively shared feature of human ITIM-containing CD33-related Siglecs (Siglec-9 and Siglec-5; Ando et al. 2008) , Siglecs may be involved in the termination of inflammation by IL-10 production. Further studies are needed to clarify the complete mechanisms and physiological roles for the increase in IL-10 production by Siglecs in more detail.
